CG Oncology, Inc. Common stock (CGON) is a publicly traded Healthcare sector company. As of September 16, 2026, CGON trades at $73.80 with a market cap of $6.54B and a P/E ratio of -27.47. CGON moved +1.23% today. Year to date, CGON is +74.74%; over the trailing twelve months it is +109.68%. Its 52-week range spans $14.80 to $80.97. Analyst consensus is strong buy with an average price target of $92.56. Rallies surfaces CGON's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for CGON combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $73.80 |
| Market Cap | $6.54B |
| P/E Ratio | -27.47 |
| EPS | $-2.69 |
| Dividend Yield | 0.00% |
| 52-Week High | $80.97 |
| 52-Week Low | $14.80 |
| Volume | 334.20K |
| Avg Volume | 0 |
| Revenue (TTM) | $6.23M |
| Net Income | $-224.38M |
| Gross Margin | 0.00% |
10 analysts cover CGON: 0 strong buy, 10 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $92.56.